Geneva, Oct. 9 -- International Clinical Trials Registry received information related to the study (ChiCTR2600133592) titled 'RealTime Predictive Value of Baseline and Dynamic Changes in Peripheral Blood Inflammatory Markers (NLR, PLR, SIRI) for Efficacy and Prognosis in Advanced NSCLC Receiving FirstLine Immunotherapy' on Sept. 29.
Study Type: Observational study
Study Design:
Sequential
Primary Sponsor: Yuebei People's Hospital
Condition:
Advanced nonsmall cell lung cancer
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-10-01
Target Sample Size: Observation group:220;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=344194
Published by HT Digit...